Biopharmaceutical company Acceleron Pharma Inc. has leased 19,711 square feet of biotechnology laboratory space at 12 Emily St. in Cambridge.
Acceleron Pharma currently occupies a total of 75,000 square feet at 128 & 149 Sidney St., and will expand its Cambridge presence to 12 Emily St. in June.
Colliers Meredith & Grew’s Joe Flaherty and Tucker Hansen represented Acceleron Pharma in the transaction. The landlord, the Massachusetts Institute of Technology, represented itself, with John McQuaid, senior real estate officer, and Patrick Rowe, senior investment associate, handling the negotiations for the school.
Specifics of the lease transaction were not disclosed.
Twelve Emily St. is a two-story, 30,000-square-foot flexible office/research and development building located two blocks from University Park at M.I.T.
"The addition of the 12 Emily St. facility provides additional wet laboratory and administrative office space adjacent to our existing other two facilities and will help support our rapid growth," said Nancy Sullivan, senior director of operations for Acceleron.
